Compound Summary
Compound Information
DL-Cycloserine
Compound Name: | DL-Cycloserine |
Compound CID: | 401 |
Synonyms: | DL-Cycloserine 4-Aminoisoxazolidin-3-one 68-39-3 4-amino-1,2-oxazolidin-3-one 4-Amino-3-isoxazolidinone More... |
Iupac Name: | 4-amino-1,2-oxazolidin-3-one |
InChI: | InChI=1S/C3H6N2O2/c4-2-1-7-5-3(2)6/h2H,1,4H2,(H,5,6) |
InChIKey: | DYDCUQKUCUHJBH-UHFFFAOYSA-N |
Canonical Smiles: | C1C(C(=O)NO1)N |
Isomeric Smiles: | C1C(C(=O)NO1)N |
Molecular Weight: | 102.09 |
Molecular Formula: | C3H6N2O2 |
Compound Structure
2D Structure:
3D Structure:
Computed Properties
DL-Cycloserine
Molecular Weight: | 102.09 |
Molecular Formula: | C3H6N2O2 |
Hydrogen Bond Donor Count: | 2 |
Hydrogen Bond Acceptor Count: | 3 |
Rotatable Bond Count: | 0 |
Heavy Atom Count: | 7 |
Complexity: | 92.9 |
Synonyms
DL-Cycloserine
| DL-Cycloserine | DL-Cycloserine |
|---|---|
DL-Cycloserine |
4-Aminoisoxazolidin-3-one |
68-39-3 |
4-amino-1,2-oxazolidin-3-one |
4-Amino-3-isoxazolidinone |
DL-4-Aminoisoxazolidin-3-one |
3-Isoxazolidinone, 4-amino- |
4-Amino-3-isoxazolidone |
3-ISOXAZOLIDINONE, 4-AMINO-, (+-)- |
DL-4-Amino-3-isoxazolidinone |
MFCD00064323 |
NSC154851 |
3-Isoxazolidinone, d- |
4-amino-4,5-dihydro-1,2-oxazol-3-ol |
3-Isoxazolidinone, (R)- |
3-Isoxazolidinone, (+)- |
WLN: T5OMVJ DZ -D |
Cycloserine, D- |
.alpha.-Cycloserine |
(+-)-4-Amino-3-isoxazolidinone |
(+-)-Oxamicina Italian |
(+-)-Oxamicina |
EINECS 200-687-9 |
(+-)-4-Amino-3-isossazolidone Italian |
AI3-61058 |
NSC-76029 |
NSC-154851 |
(+-)-4-Amino-3-isossazolidone |
3-Isoxazolidinone,4-amino-, (4R)- |
ACMC-209tyq |
ACMC-20a5jd |
DL-Cycloserine crystalline |
4-Amino-isoxazolidin-3-on |
DL-Cycloserine, crystalline |
3-Isoxazolidinone,4-amino- |
4-Amino-isoxazolidin-3-one |
Lopac0_000267 |
SCHEMBL34323 |
4-amino-2-isoxazoline-3-ol |
4-Amino-3-isoxazolidinone # |
CHEBI:23503 |
DTXSID40859074 |
HMS3260F16 |
HMS3370D10 |
HMS3374E09 |
HMS3393C15 |
Pharmakon1600-01506178 |
ACT10891 |
BCP22967 |
BCP22968 |
NSC76029 |
Tox21_500267 |
BBL016489 |
NSC760409 |
STK177281 |
STL454326 |
AKOS005410669 |
CCG-204362 |
CS-W008440 |
LP00267 |
MCULE-3159218372 |
NSC-760409 |
SB23044 |
SDCCGSBI-0050255.P002 |
VZ28241 |
NCGC00015213-04 |
NCGC00015213-05 |
NCGC00015213-06 |
NCGC00015213-07 |
NCGC00015213-08 |
NCGC00015213-11 |
NCGC00093725-01 |
NCGC00093725-02 |
NCGC00093725-03 |
NCGC00093725-04 |
NCGC00260952-01 |
BP-20174 |
DS-18396 |
SY005636 |
AB0007231 |
DB-055147 |
DB-055151 |
DB-068913 |
AM20100628 |
EU-0100267 |
FT-0624464 |
FT-0631297 |
FT-0665409 |
FT-0696808 |
Z5032 |
O-Isobutyl (3,4-dichlorophenyl)carbamothioate |
C 7005 |
C06682 |
064C323 |
A855990 |
A858006 |
SR-01000075776 |
SR-01000075776-1 |
W-104673 |
Q27109800 |
Cycloserine; Seromycin; Orientomycin; Oxamycin; Seromycin |
(S)-4-Amino-3-isoxazolidone; (S)-Cycloserine;Levcycloserine |
Experimental Data
DL-Cycloserine
| Species | Dosage | Unit | CG Lifespan(AVG/MED days) | TG Lifespan(AVG/MED days) | Lifespan Change(AVG/MED%) | CG Lifespan(MAX days) | TG Lifespan(MAX days) | Lifespan Change(MAX%) | Significant | Strain | Gender | PubMed | Active Label |
|---|---|---|---|---|---|---|---|---|---|---|---|---|---|
| Caenorhabditis elegans | 33 | umol/L | -3 | NS | N2 | 24134630 | Inactive |
Experimental Data Visualization
DL-Cycloserine
Statistics Data
DL-Cycloserine
| Species | Lifespan Change(AVG/MED%) | Lifespan Change(MAX%) | Count Reference | Count Data point |
|---|---|---|---|---|
| Caenorhabditis elegans | -3 | 1 | 1 |
Statistics Data Visualization
DL-Cycloserine
